Fund details
Series |
Currency |
Fund code |
MER * (%) |
|---|---|---|---|
| F | CAD | 35071 | 0.99% |
Portfolio analysis As of Aug 31, 2025
98%
2%
Equity
Fixed Income
Asset mix
Equity Sector Allocation
Financials27.0%
Industrials19.5%
Consumer Discretionary11.1%
Health Care10.9%
Consumer Staples7.4%
Materials6.6%
Communication Services5.2%
Information Technology4.9%
Energy3.7%
Utilities3.7%
Top 10 Holdings |
% Assets |
|---|---|
| Roche Holding AG | 2.7% |
| British American Tobacco PLC | 2.6% |
| Mitsubishi Heavy Industries Ltd | 2.4% |
| Iberdrola SA | 2.4% |
| Tokio Marine Holdings Inc | 2.3% |
| AstraZeneca PLC | 2.1% |
| Unilever PLC | 2.1% |
| AIA Group Ltd | 2.1% |
| ASML Holding NV | 2.0% |
| ING Groep NV | 2.0% |
| Total % of Top 10 Holdings | 22.7% |
Geographic allocation
Region
- Europe66.6%
- Asia33.4%
Performance analysis
Growth of $10,000 since inception
Calendar returns
Trailing return
| 1 Mth | 3 Mth | 6 Mth | 1 year | 3 years | 5 years | 10 years | Since Inception | |||
|---|---|---|---|---|---|---|---|---|---|---|
| 2.5 | 5.8 | 11.2 | 13.1 | 19.6 | 8.8 | 7.1 | 5.3 | Fund |
Distribution ($)/unit
| YTD* | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total distributions | 0.24 | 0.29 | 0.25 | 0.53 | --- | 0.11 | 0.15 | 0.13 | 0.06 | 0.12 | 0.18 |
| Interest | --- | 0.00 | 0.00 | 0.00 | --- | 0.05 | 0.00 | 0.00 | --- | --- | --- |
| Canadian dividends | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Foreign dividends | --- | 0.34 | 0.29 | 0.56 | --- | 0.07 | 0.18 | 0.17 | 0.08 | 0.15 | 0.22 |
| Foreign taxes paid | --- | -0.05 | -0.04 | -0.03 | --- | -0.02 | -0.03 | -0.04 | -0.02 | -0.03 | -0.04 |
| Capital gains | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return of capital | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
* MER (%) is based on actual expenses for the preceding calendar year or most recent half-year period ended June 30 expressed on an annualized basis, depending on availability of date at the time of publication.